Augmentation of kallikrein and plasmin inhibition capacity by aprotinin using a new assay to monitor therapy

Adv Exp Med Biol. 1989:247B:55-60. doi: 10.1007/978-1-4615-9546-5_9.
No abstract available

MeSH terms

  • Aprotinin / therapeutic use*
  • Cardiopulmonary Bypass*
  • Fibrinolysin / antagonists & inhibitors*
  • Humans
  • Kallikreins / blood*
  • Kinetics
  • Monitoring, Physiologic

Substances

  • Aprotinin
  • Kallikreins
  • Fibrinolysin